{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T00:22:57Z","timestamp":1718497377700},"reference-count":37,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,15]]},"DOI":"10.7759\/cureus.62441","type":"journal-article","created":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T17:04:07Z","timestamp":1718471047000},"source":"Crossref","is-referenced-by-count":0,"title":["Association of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) With an Increased Risk of Congestive Heart Failure in Hospitalized Patients With Cirrhosis: A Propensity Score-Matched Analysis"],"prefix":"10.7759","author":[{"given":"Derek","family":"Ugwendum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mouhanad","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yazan A","family":"Al-Ajlouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nso","family":"Nso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basile","family":"Njei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani N","year":"2012","unstructured":"Chalasani N, Younossi Z, Lavine JE, et al.. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012, 55:2005-23. 10.1002\/hep.25762","journal-title":"Hepatology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.03.020","article-title":"Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008","volume":"9","author":"Younossi ZM","year":"2011","unstructured":"Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, Srishord M. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol. 2011, 9:524-530.e1; quiz e60. 10.1016\/j.cgh.2011.03.020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i43.9488","article-title":"Nonalcoholic fatty liver disease - a multisystem disease?","volume":"22","author":"Mikolasevic I","year":"2016","unstructured":"Mikolasevic I, Milic S, Turk Wensveen T, et al.. Nonalcoholic fatty liver disease - a multisystem disease?. World J Gastroenterol. 2016, 22:9488-505. 10.3748\/wjg.v22.i43.9488","journal-title":"World J Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i26.8407","article-title":"Nonalcoholic fatty liver disease and cardiovascular disease","volume":"20","author":"Liu H","year":"2014","unstructured":"Liu H, Lu HY. Nonalcoholic fatty liver disease and cardiovascular disease. World J Gastroenterol. 2014, 20:8407-15. 10.3748\/wjg.v20.i26.8407","journal-title":"World J Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/srep33386","article-title":"Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: a systematic review and meta-analysis","volume":"6","author":"Wu S","year":"2016","unstructured":"Wu S, Wu F, Ding Y, Hou J, Bi J, Zhang Z. Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: a systematic review and meta-analysis. Sci Rep. 2016, 6:33386. 10.1038\/srep33386","journal-title":"Sci Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2147\/RMHP.S130341","article-title":"Economic burden of hospitalizations of Medicare beneficiaries with heart failure","volume":"10","author":"Kilgore M","year":"2017","unstructured":"Kilgore M, Patel HK, Kielhorn A, Maya JF, Sharma P. Economic burden of hospitalizations of Medicare beneficiaries with heart failure. Risk Manag Healthc Policy. 2017, 10:63-70. 10.2147\/RMHP.S130341","journal-title":"Risk Manag Healthc Policy"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.09.038","article-title":"Rehospitalization for heart failure: problems and perspectives","volume":"61","author":"Gheorghiade M","year":"2013","unstructured":"Gheorghiade M, Vaduganathan M, Fonarow GC, Bonow RO. Rehospitalization for heart failure: problems and perspectives. J Am Coll Cardiol. 2013, 61:391-403. 10.1016\/j.jacc.2012.09.038","journal-title":"J Am Coll Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002760","article-title":"Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure","volume":"95","author":"Valbusa F","year":"2016","unstructured":"Valbusa F, Bonapace S, Grillo C, et al.. Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure. Medicine (Baltimore). 2016, 95:e2760. 10.1097\/MD.0000000000002760","journal-title":"Medicine (Baltimore)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173398","article-title":"Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure","volume":"12","author":"Valbusa F","year":"2017","unstructured":"Valbusa F, Bonapace S, Agnoletti D, et al.. Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure. PLoS One. 2017, 12:e0173398. 10.1371\/journal.pone.0173398","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.111.228262","article-title":"Hepatic steatosis, obesity, and the metabolic syndrome are independently and additively associated with increased systemic inflammation","volume":"31","author":"Ndumele CE","year":"2011","unstructured":"Ndumele CE, Nasir K, Concei\u00e7ao RD, Carvalho JA, Blumenthal RS, Santos RD. Hepatic steatosis, obesity, and the metabolic syndrome are independently and additively associated with increased systemic inflammation. Arterioscler Thromb Vasc Biol. 2011, 31:1927-32. 10.1161\/ATVBAHA.111.228262","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2015.02.032","article-title":"Relation of nonalcoholic fatty liver disease and Framingham Risk Score to flow-mediated dilation in patients with cardiometabolic risk factors","volume":"115","author":"Pastori D","year":"2015","unstructured":"Pastori D, Loffredo L, Perri L, et al.. Relation of nonalcoholic fatty liver disease and Framingham Risk Score to flow-mediated dilation in patients with cardiometabolic risk factors. Am J Cardiol. 2015, 115:1402-6. 10.1016\/j.amjcard.2015.02.032","journal-title":"Am J Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i38.6453","article-title":"Nonalcoholic fatty liver disease is associated with coronary artery disease in Koreans","volume":"19","author":"Choi DH","year":"2013","unstructured":"Choi DH, Lee SJ, Kang CD, et al.. Nonalcoholic fatty liver disease is associated with coronary artery disease in Koreans. World J Gastroenterol. 2013, 19:6453-7. 10.3748\/wjg.v19.i38.6453","journal-title":"World J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American Heart Association","volume":"42","author":"Duell PB","year":"2022","unstructured":"Duell PB, Welty FK, Miller M, et al.. Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American Heart Association. Arterioscler Thromb Vasc Biol. 2022, 42:e168-85. 10.1161\/ATV.0000000000000153","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-009-0935-9","article-title":"Association between nonalcoholic fatty liver disease and coronary artery calcification","volume":"55","author":"Chen CH","year":"2010","unstructured":"Chen CH, Nien CK, Yang CC, Yeh YH. Association between nonalcoholic fatty liver disease and coronary artery calcification. Dig Dis Sci. 2010, 55:1752-60. 10.1007\/s10620-009-0935-9","journal-title":"Dig Dis Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1253\/circj.72.618","article-title":"Evaluation of vulnerable coronary plaques and non-alcoholic fatty liver disease (NAFLD) by 64-detector multislice computed tomography (MSCT)","volume":"72","author":"Akabame S","year":"2008","unstructured":"Akabame S, Hamaguchi M, Tomiyasu K, et al.. Evaluation of vulnerable coronary plaques and non-alcoholic fatty liver disease (NAFLD) by 64-detector multislice computed tomography (MSCT). Circ J. 2008, 72:618-25. 10.1253\/circj.72.618","journal-title":"Circ J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.112.252957","article-title":"Nonalcoholic fatty liver disease is associated with atherosclerosis in middle-aged and elderly Chinese","volume":"32","author":"Huang Y","year":"2012","unstructured":"Huang Y, Bi Y, Xu M, et al.. Nonalcoholic fatty liver disease is associated with atherosclerosis in middle-aged and elderly Chinese. Arterioscler Thromb Vasc Biol. 2012, 32:2321-6. 10.1161\/ATVBAHA.112.252957","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1283218","article-title":"Carotid intima-media thickness and liver histology in hemodialysis patients with nonalcoholic fatty liver disease","volume":"20","author":"Neri S","year":"2011","unstructured":"Neri S, Signorelli SS, Scuderi R, et al.. Carotid intima-media thickness and liver histology in hemodialysis patients with nonalcoholic fatty liver disease. Int J Angiol. 2011, 20:149-56. 10.1055\/s-0031-1283218","journal-title":"Int J Angiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22845","article-title":"Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population","volume":"49","author":"Gastaldelli A","year":"2009","unstructured":"Gastaldelli A, Kozakova M, H\u00f8jlund K, Flyvbjerg A, Favuzzi A, Mitrakou A, Balkau B. Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology. 2009, 49:1537-44. 10.1002\/hep.22845","journal-title":"Hepatology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-0135","article-title":"Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease","volume":"29","author":"Targher G","year":"2006","unstructured":"Targher G, Bertolini L, Padovani R, et al.. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care. 2006, 29:1325-30. 10.2337\/dc06-0135","journal-title":"Diabetes Care"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i12.1848","article-title":"Hepatic steatosis is associated with an increased risk of carotid atherosclerosis","volume":"11","author":"Volzke H","year":"2005","unstructured":"Volzke H, Robinson DM, Kleine V, et al.. Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. World J Gastroenterol. 2005, 11:1848-53. 10.3748\/wjg.v11.i12.1848","journal-title":"World J Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0904944106","article-title":"Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity","volume":"106","author":"Fabbrini E","year":"2009","unstructured":"Fabbrini E, Magkos F, Mohammed BS, et al.. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A. 2009, 106:15430-5. 10.1073\/pnas.0904944106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1820","article-title":"Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes","volume":"35","author":"Bonapace S","year":"2012","unstructured":"Bonapace S, Perseghin G, Molon G, et al.. Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes. Diabetes Care. 2012, 35:389-95. 10.2337\/dc11-1820","journal-title":"Diabetes Care"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27869","article-title":"Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study","volume":"62","author":"VanWagner LB","year":"2015","unstructured":"VanWagner LB, Wilcox JE, Colangelo LA, et al.. Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study. Hepatology. 2015, 62:773-83. 10.1002\/hep.27869","journal-title":"Hepatology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/oby.21879","article-title":"Nonalcoholic steatohepatitis is associated with cardiac remodeling and dysfunction","volume":"25","author":"Simon TG","year":"2017","unstructured":"Simon TG, Bamira DG, Chung RT, Weiner RB, Corey KE. Nonalcoholic steatohepatitis is associated with cardiac remodeling and dysfunction. Obesity (Silver Spring). 2017, 25:1313-6. 10.1002\/oby.21879","journal-title":"Obesity (Silver Spring)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.06.180","article-title":"Echocardiography and NAFLD (non-alcoholic fatty liver disease)","volume":"221","author":"Trovato FM","year":"2016","unstructured":"Trovato FM, Martines GF, Catalano D, Musumeci G, Pirri C, Trovato GM. Echocardiography and NAFLD (non-alcoholic fatty liver disease). Int J Cardiol. 2016, 221:275-9. 10.1016\/j.ijcard.2016.06.180","journal-title":"Int J Cardiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i10.1579","article-title":"Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease","volume":"13","author":"Hamaguchi M","year":"2007","unstructured":"Hamaguchi M, Kojima T, Takeda N, et al.. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol. 2007, 13:1579-84. 10.3748\/wjg.v13.i10.1579","journal-title":"World J Gastroenterol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2011.242016","article-title":"Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease","volume":"60","author":"Wong VW","year":"2011","unstructured":"Wong VW, Wong GL, Yip GW, et al.. Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut. 2011, 60:1721-7. 10.1136\/gut.2011.242016","journal-title":"Gut"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-004973","article-title":"Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study","volume":"4","author":"Pisto P","year":"2014","unstructured":"Pisto P, Santaniemi M, Bloigu R, Ukkola O, Kes\u00e4niemi YA. Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study. BMJ Open. 2014, 4:e004973. 10.1136\/bmjopen-2014-004973","journal-title":"BMJ Open"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186720","article-title":"Severity of coronary artery disease is associated with non-alcoholic fatty liver dis-ease: a single-blinded prospective mono-center study","volume":"12","author":"Friedrich-Rust M","year":"2017","unstructured":"Friedrich-Rust M, Schoelzel F, Maier S, et al.. Severity of coronary artery disease is associated with non-alcoholic fatty liver dis-ease: a single-blinded prospective mono-center study. PLoS One. 2017, 12:e0186720. 10.1371\/journal.pone.0186720","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.02.045","article-title":"Hepatic steatosis and cardiovascular disease outcomes: an analysis of the Framingham Heart Study","volume":"63","author":"Mellinger JL","year":"2015","unstructured":"Mellinger JL, Pencina KM, Massaro JM, et al.. Hepatic steatosis and cardiovascular disease outcomes: an analysis of the Framingham Heart Study. J Hepatol. 2015, 63:470-6. 10.1016\/j.jhep.2015.02.045","journal-title":"J Hepatol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.12.039","article-title":"Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population","volume":"10","author":"Stepanova M","year":"2012","unstructured":"Stepanova M, Younossi ZM. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population. Clin Gastroenterol Hepatol. 2012, 10:646-50. 10.1016\/j.cgh.2011.12.039","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d6891","article-title":"Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study","volume":"343","author":"Lazo M","year":"2011","unstructured":"Lazo M, Hernaez R, Bonekamp S, Kamel IR, Brancati FL, Guallar E, Clark JM. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ. 2011, 343:d6891. 10.1136\/bmj.d6891","journal-title":"BMJ"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-017-1113-1","article-title":"The impact of non-alcoholic fatty liver disease fibrosis score on cardiac prognosis in patients with chronic heart failure","volume":"33","author":"Takahashi T","year":"2018","unstructured":"Takahashi T, Watanabe T, Shishido T, et al.. The impact of non-alcoholic fatty liver disease fibrosis score on cardiac prognosis in patients with chronic heart failure. Heart Vessels. 2018, 33:733-9. 10.1007\/s00380-017-1113-1","journal-title":"Heart Vessels"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.1165","article-title":"Non-alcoholic fatty liver disease association with cardiac arrhythmias","volume":"9","author":"Mangi MA","year":"2017","unstructured":"Mangi MA, Rehman H, Minhas AM, Rafique M, Bansal V, Constantin J. Non-alcoholic fatty liver disease association with cardiac arrhythmias. Cureus. 2017, 9:e1165. 10.7759\/cureus.1165","journal-title":"Cureus"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185459","article-title":"Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus","volume":"12","author":"Mantovani A","year":"2017","unstructured":"Mantovani A, Rigolon R, Pichiri I, et al.. Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus. PLoS One. 2017, 12:e0185459. 10.1371\/journal.pone.0185459","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142937","article-title":"Non-alcoholic fatty liver disease as a predictor of atrial fibrillation in middle-aged population (OPERA study)","volume":"10","author":"K\u00e4r\u00e4j\u00e4m\u00e4ki AJ","year":"2015","unstructured":"K\u00e4r\u00e4j\u00e4m\u00e4ki AJ, P\u00e4tsi OP, Savolainen M, Kes\u00e4niemi YA, Huikuri H, Ukkola O. Non-alcoholic fatty liver disease as a predictor of atrial fibrillation in middle-aged population (OPERA study). PLoS One. 2015, 10:e0142937. 10.1371\/journal.pone.0142937","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1042\/CS20130036","article-title":"Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes","volume":"125","author":"Targher G","year":"2013","unstructured":"Targher G, Mantovani A, Pichiri I, et al.. Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes. Clin Sci (Lond). 2013, 125:301-9. 10.1042\/CS20130036","journal-title":"Clin Sci (Lond)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/258284-association-of-metabolic-dysfunction-associated-steatotic-liver-disease-masld-with-an-increased-risk-of-congestive-heart-failure-in-hospitalized-patients-with-cirrhosis-a-propensity-score-matched-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T17:04:11Z","timestamp":1718471051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/258284-association-of-metabolic-dysfunction-associated-steatotic-liver-disease-masld-with-an-increased-risk-of-congestive-heart-failure-in-hospitalized-patients-with-cirrhosis-a-propensity-score-matched-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,15]]},"references-count":37,"URL":"https:\/\/doi.org\/10.7759\/cureus.62441","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,15]]}}}